SIGLEC7
Basic information
Region (hg38): 19:51142299-51153526
Previous symbols: [ "SIGLEC19P", "SIGLECP2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIGLEC7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 0 | 1 |
Variants in SIGLEC7
This is a list of pathogenic ClinVar variants found in the SIGLEC7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-51142411-G-C | not specified | Uncertain significance (Jan 20, 2025) | ||
19-51142440-A-C | not specified | Uncertain significance (Nov 13, 2024) | ||
19-51142497-A-C | not specified | Uncertain significance (Jul 26, 2021) | ||
19-51142503-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
19-51142515-C-G | not specified | Uncertain significance (Mar 14, 2023) | ||
19-51142593-A-G | not specified | Uncertain significance (Nov 13, 2024) | ||
19-51142598-C-T | not specified | Uncertain significance (Feb 09, 2025) | ||
19-51142644-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
19-51142658-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
19-51142695-G-A | not specified | Uncertain significance (Feb 03, 2025) | ||
19-51142722-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
19-51142796-G-A | not specified | Uncertain significance (Apr 06, 2022) | ||
19-51144466-A-G | not specified | Uncertain significance (Jun 07, 2023) | ||
19-51144480-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
19-51144501-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
19-51144505-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
19-51144513-A-G | Benign (Dec 11, 2017) | |||
19-51144537-G-T | not specified | Uncertain significance (Apr 04, 2024) | ||
19-51144564-C-T | not specified | Uncertain significance (Feb 09, 2025) | ||
19-51144580-C-A | not specified | Uncertain significance (Jan 22, 2025) | ||
19-51144602-C-G | not specified | Uncertain significance (Nov 25, 2024) | ||
19-51144640-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
19-51144668-C-G | not specified | Uncertain significance (Jun 02, 2023) | ||
19-51145866-C-A | not specified | Uncertain significance (Oct 19, 2024) | ||
19-51145899-G-C | not specified | Uncertain significance (Jul 13, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIGLEC7 | protein_coding | protein_coding | ENST00000317643 | 7 | 11228 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.39e-7 | 0.729 | 125625 | 1 | 121 | 125747 | 0.000485 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.859 | 221 | 260 | 0.850 | 0.0000140 | 2999 |
Missense in Polyphen | 59 | 72.885 | 0.80949 | 942 | ||
Synonymous | -0.118 | 114 | 112 | 1.01 | 0.00000643 | 984 |
Loss of Function | 1.27 | 13 | 18.9 | 0.686 | 9.64e-7 | 195 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00440 | 0.00441 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000257 | 0.000193 |
Middle Eastern | 0.00440 | 0.00441 |
South Asian | 0.000369 | 0.000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid. Also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNAc lactotetraoslylceramide). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Mediates inhibition of natural killer cells cytotoxicity. May play a role in hemopoiesis. Inhibits differentiation of CD34+ cell precursors towards myelomonocytic cell lineage and proliferation of leukemic myeloid cells (in vitro). {ECO:0000269|PubMed:10611343}.;
- Pathway
- Microglia Pathogen Phagocytosis Pathway;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Intolerance Scores
- loftool
- 0.860
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.06
Haploinsufficiency Scores
- pHI
- 0.0452
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0708
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cell adhesion;regulation of immune response
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- carbohydrate binding;signaling receptor activity